“Under Secretary Kennedy’s leadership, all new vaccines will undergo safety testing in placebo-controlled trials prior to ...

Samsung Biologics, which has enjoyed a booming contract drug manufacturing streak over the past year, has inked another ...

Dynavax is kicking off May’s Hepatitis Awareness Month with a new push to improve education around hepatitis B and the ...

As GSK weathers the storm of sinking vaccine sales and gears up for key launches in its specialty medicines sector, the ...

While Johnson & Johnson isn't the first to secure FDA approval for an FcRn-blocking antibody in myasthenia gravis, the New ...

Six months after entering talks with U.S. private equity firm Clayton, Dubilier & Rice (CD&R), Sanofi has closed a deal to ...

A new commercial for AstraZeneca’s Truqap constructs a vision of the extra time that the AKT inhibitor can unlock for some ...

Charles Barkley is going on the offense after seeing his weight rebound. | Charles Barkley is going on the offense after ...

Despite formidable competition in the growing transthyretin amyloid cardiomyopathy (ATTR-CM) market, a strong early launch ...

Over the years, a host of large drugmakers have inked settlements with the federal authorities to resolve allegations that ...

Once again, several members of Congress have come together to call for an end to the tax deductions that drugmakers receive ...

Novo Nordisk appears to be letting compounded GLP-1 bygones be bygones—at least, in one respect. | Novo Nordisk appears to be ...